Moors & Cabot Inc. Has $6.18 Million Stock Holdings in CME Group Inc. (NASDAQ:CME)

Moors & Cabot Inc. grew its position in shares of CME Group Inc. (NASDAQ:CME) by 10.0% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 31,452 shares of the financial services provider’s stock after acquiring an additional 2,853 shares during the quarter. Moors & Cabot Inc.’s holdings in CME Group were worth $6,183,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of the company. Gold Investment Management Ltd. bought a new position in shares of CME Group in the 4th quarter valued at about $26,000. Salomon & Ludwin LLC acquired a new position in CME Group during the first quarter valued at approximately $28,000. Y.D. More Investments Ltd bought a new position in CME Group in the second quarter valued at approximately $36,000. McClarren Financial Advisors Inc. increased its position in shares of CME Group by 66.1% during the 2nd quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock worth $39,000 after purchasing an additional 78 shares during the last quarter. Finally, Asset Dedication LLC raised its stake in shares of CME Group by 515.2% during the 2nd quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock worth $40,000 after purchasing an additional 170 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on CME shares. Deutsche Bank Aktiengesellschaft raised their target price on shares of CME Group from $193.00 to $200.00 and gave the company a “hold” rating in a research note on Thursday, August 15th. Bank of America downgraded shares of CME Group from a “neutral” rating to an “underperform” rating and decreased their price objective for the company from $212.00 to $177.00 in a research report on Tuesday, September 3rd. JPMorgan Chase & Co. upped their target price on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a report on Thursday, July 25th. Piper Sandler reiterated an “overweight” rating and issued a $225.00 target price on shares of CME Group in a research note on Tuesday, August 20th. Finally, Keefe, Bruyette & Woods boosted their price target on CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a research report on Thursday, July 25th. Four analysts have rated the stock with a sell rating, five have given a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, CME Group presently has an average rating of “Hold” and an average price target of $209.73.

Insiders Place Their Bets

In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the transaction, the director now owns 55,607 shares in the company, valued at approximately $11,932,706.13. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 0.30% of the company’s stock.

CME Group Price Performance

CME Group stock opened at $218.53 on Tuesday. The company has a market capitalization of $78.69 billion, a price-to-earnings ratio of 24.86, a PEG ratio of 8.85 and a beta of 0.55. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $223.80. The stock’s 50 day moving average is $206.16 and its 200-day moving average is $207.48.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.53 by $0.03. The business had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.53 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The firm’s quarterly revenue was up 12.7% on a year-over-year basis. During the same period in the previous year, the company posted $2.30 EPS. Equities research analysts expect that CME Group Inc. will post 9.94 EPS for the current year.

CME Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Monday, September 9th will be given a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a yield of 2.10%. The ex-dividend date of this dividend is Monday, September 9th. CME Group’s dividend payout ratio is 52.33%.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.